|
Showing the most relevant articles for your search:TSX:FRX 1 | Date | Time | Source | Headline | Symbol | Company | | 03/18/2024 | 3:00AM | PR Newswire (US) | Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand | TSX:FRX | Fennec Pharmaceuticals Inc |
| 09/13/2017 | 12:39PM | PR Newswire (Canada) | L'OCRCVM permet la reprise de la négociation - FRX | TSX:FRX | Fennec Pharmaceuticals Inc |
| 09/13/2017 | 12:35PM | PR Newswire (Canada) | IIROC Trade Resumption - FRX | TSX:FRX | Fennec Pharmaceuticals Inc |
| 09/13/2017 | 9:32AM | PR Newswire (Canada) | Suspension de la négociation par l'OCRCVM - FRX | TSX:FRX | Fennec Pharmaceuticals Inc |
| 09/13/2017 | 9:29AM | PR Newswire (Canada) | IIROC Trading Halt - FRX | TSX:FRX | Fennec Pharmaceuticals Inc |
| 06/01/2015 | 11:00AM | PR Newswire (US) | Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting | TSX:FRX | Fennec Pharmaceuticals Inc |
| 08/27/2009 | 6:31PM | PR Newswire (US) | Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and Reduce | NYSE:FRX | |
| 08/10/2009 | 7:00AM | PR Newswire (US) | Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPD | NYSE:FRX | |
| 06/22/2009 | 9:20AM | PR Newswire (US) | Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and Wyndham | NYSE:FRX | |
| 05/20/2008 | 11:30AM | PR Newswire (US) | Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic f | NYSE:FRX | |
| 11/08/2007 | 8:30AM | PR Newswire (US) | Milnacipran Demonstrated Significant Improvement in Pain and the Core Symptoms of Fibromyalgia Syndrome, Data Show | NYSE:FRX | |
| 05/01/2007 | 11:49AM | PR Newswire (US) | Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol | NYSE:FRX | |
| 02/15/2006 | 6:07PM | PR Newswire (US) | /C O R R E C T I O N -- Forest Laboratories, Inc./ | NYSE:FRX | |
|
Showing the most relevant articles for your search:TSX:FRX 1 |
|